- Outlook on the Life Sciences Industry🔍
- LIFE SCIENCES AND BIOMANUFACTURING STRATEGY🔍
- The Global Use of Medicines 2024🔍
- Life Sciences🔍
- Chancellor reveals life sciences growth package to fire up economy🔍
- 5 things to know in life sciences🔍
- Analyzing 2023 Technology Trends in the Life Sciences Industry🔍
- Global Life Sciences Equity Fund🔍
2023 Global Life Sciences Outlook
Outlook on the Life Sciences Industry: 2024 and Beyond - Labcompare
While traditionally laboratories have been slow to embrace digitization, the Horizons: Life Sciences 2023 reports suggests companies are now ...
LIFE SCIENCES AND BIOMANUFACTURING STRATEGY - Gov.bc.ca
Government of British Columbia / 2023 Life Sciences and Biomanufacturing Strategy / ... global life sciences ecosystem. This strategy invests in talent ...
The Global Use of Medicines 2024: Outlook to 2028 - IQVIA
The higher growth in 2023 driven by non-COVID-19 therapies is expected to continue, raising the five-year outlook by 2%. COVID-19 vaccines and ...
Life Sciences: Trends & Outlook – April 2024 - Savills US
In 2023, life sciences firms in the area secured US$1.2 billion across 209 deals, an increase from pre-pandemic levels. A notable funding deal ...
Chancellor reveals life sciences growth package to fire up economy
A £650 million war-chest to fire up the UK's life sciences sector and drive forward the government's priority to grow the economy has been unveiled by the ...
5 things to know in life sciences: Week of Sept. 11, 2023
5 things to know in life sciences: Week of Sept. 11, 2023 · FDA approves updated COVID-19 vaccines · Neumora, RayzeBio seek $200 million+ in ...
Analyzing 2023 Technology Trends in the Life Sciences Industry
Accenture's report highlighted technology trends in the biopharma industry throughout 2023. · Rapid Innovation · GenAI · Data as the Lifeblood.
Global Life Sciences Equity Fund - Janus Henderson Investors
INVESTMENT OUTLOOK 2024 ... Brighter Future Project ... We provide access to some of the industry's most talented and innovative thinkers. ... The Brighter Future ...
Biopharmaceutical Sector Outlook for 2024 – Jan 5, 2024 - Stifel
Period (Oct 27 to Dec 30, 2023, Global Life Sciences Sector). Page 66 … But Short Covering Had Little to Do with the Rally Overall. 66. Even ...
Life Sciences 2023 | Clarion Partners Real Estate Investment
After record years in 2020 and 2021, U.S. life sciences sector performance moderated in 2022 and into 2023. This slowdown is largely related to ...
Life Science Analytics Market Growth, Drivers, and Opportunities
The global life science analytics market is expected to reach USD 61.94 billion by 2029 from USD 35.69 billion in 2024, at a CAGR of 11.7% during the forecast ...
7 Trends We Expect To See In Life Sciences Throughout 2024
Adaptability, global collaboration, supply chain innovation and mRNA technologies were just some of the key trends in 2023. Rephine's Dr. Eduard ...
Deloitte on X: "#Vaccines and next-generation treatments like #cell ...
Our 2023 Global Life Sciences Outlook discusses more. https://t.co/GG838JVDWL. ... Our 2023 Global Life Sciences Outlook discusses more. https:// ...
New: 6 essential pharmaceutical industry statistics to know in 2024
Check out our 2023 life science industry predictions, 5 current pharma ... global-life-sciences-outlook-report.pdf. Cowen. Speeding Innovation: A Primer ...
2024 Global Quality Outlook | Scilife
Discover the main trends that will shape the future of Quality and Life Sciences in 2024: Data Integrity, Quality 4.0, Artificial Intelligence, and more!
CBRE Report 2023: A Snapshot of the Philadelphia Life Sciences ...
The report says that U.S. life sciences employment hit a record 2.1 million jobs at the beginning of 2023. Perhaps not surprisingly, the San ...
Life Science Software Market Size, Share, Trends - 2033 | FMI
Life Science Software Market Outlook (2023 to 2033) ... The global life science software market is expected to reach a valuation of US$ 13,736 million in 2023.
Life sciences report 2023: trends and future risks - Kennedys Law
Pioneering treatments and therapies continue to be a priority for life sciences companies. The development and use of personalised medicine has ...
The year the United Kingdom becomes a globally leading life ...
From an investment perspective, global macro-economic factors led to a very slow start to 2023 for pharma and biotech investment and M&A.
Life Sciences 2023 Year End Review / 2024 Outlook - Gibson Dunn
Strong capital markets and M&A activity into early 2020 were whipsawed during the pandemic, with equity valuations climbing significantly through early 2021 ...